| Followers | 0 |
| Posts | 69 |
| Boards Moderated | 0 |
| Alias Born | 02/14/2021 |
Tuesday, March 02, 2021 10:02:43 AM
Please tell me where the hearsay & pumping is:
Hearsay:
(1) Dr. Linda Liau told sentimemt_stocks to her face that “ATL-DC is DCVax”, and (2) Dr Bala’s recording of the UCLA researcher who stated “there are other dendritic cell vaccine, but at UCLA we use DCVax”.
This is hearsay. It may turn out to be true, but you can't deny it's hearsay. I learned a long time ago not to put too much stock in hearsay because while it's sometimes true, there are other times when it will burn you.
Pump:
I personally believe that UCLA, Merck & NWBio want to purposely hide, obscure & downplay the connections between the 3 entities, and hide this DCVax-L + Keytruda combination clinical trial in plain sight.
As I've said before, it's fine to be a proponent of NWBO and DCVax. I'd like to believe this project will be successful myself even as the rational side of me is screaming that something is very wrong. If you have a different view that's fine as long as it's rational and takes in the whole picture. What bothers me is the excessive nature of hype that takes every indicator, even indicators that are obviously concerning, and turns them into a completely invented narrative that everything is humming along swimmingly. That's what this example does by twisting the rational view into an irrational view that fits your narrative. There are many hundreds of examples I could pull from other posts and Tweets, all accompanied by the disingenuous claim that they aren't intended to convince anyone of anything. I call that gaslighting, because what is really happening is shilling on behalf of the company.
The best indicator we have is the past history of NWBO, and that history tells us nothing ever hums along swimmingly with this company. The past history tells us there are more lies, rug pulls and can kicks to come - because that's what they've always done.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
